{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:59:39Z","timestamp":1790794779584,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04576-2","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:36:23Z","timestamp":1790793383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Venous and arterial thromboembolic events associated with osimertinib in patients with lung cancer: a study by the thrombosis and cancer group of the spanish society of medical oncology (SEOM)"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-4101","authenticated-orcid":false,"given":"Manuel","family":"S\u00e1nchez C\u00e1novas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"L\u00f3pez Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candela","family":"Fern\u00e1ndez Reino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificaci\u00f3n","family":"Mart\u00ednez de Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Cacho Lav\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo","family":"Rogado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Garc\u00eda Verdejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Lage Alfranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Rup\u00e9rez Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Guti\u00e9rrez Toribio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Mart\u00edn Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier-David","family":"Ben\u00edtez-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Quintanar Verduguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Pelegr\u00edn Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Cuellar Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Garc\u00eda L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Brozos-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Soto Alsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Hern\u00e1ndez-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mart\u00ednez Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J.","family":"Mu\u00f1oz Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"4576_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejim.2020.05.031","volume":"78","author":"A Carmona-Bayonas","year":"2018","unstructured":"Carmona-Bayonas A, G\u00f3mez D, Mart\u00ednez de Castro E, P\u00e9rez Segura P, Mu\u00f1oz Langa J, Jimenez-Fonseca P, et al. A snapshot of cancer-associated thromboembolic disease in 2018-2019: first data from the TESEO prospective registry. Eur J Intern Med. 2018;78:41\u20139. https:\/\/doi.org\/10.1016\/j.ejim.2020.05.031.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"4576_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12094-018-1978-1","volume":"21","author":"M Majem","year":"2018","unstructured":"Majem M, Juan O, Insa A, Reguart N, Trigo JM, Carcereny E, et al. SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018). Clin Transl Oncol. 2018;21(1):3\u201317. https:\/\/doi.org\/10.1007\/s12094-018-1978-1.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"4576_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","volume":"34","author":"LE Hendriks","year":"2023","unstructured":"Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(4):339\u201357. https:\/\/doi.org\/10.1016\/j.annonc.2022.12.009.","journal-title":"Ann Oncol"},{"key":"4576_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.thromres.2016.10.020","volume":"148","author":"M Alexander","year":"2016","unstructured":"Alexander M, Burbury K. A systematic review of biomarkers for the prediction of thromboembolism in lung cancer - Results, practical issues and proposed strategies for future risk prediction models. Thromb Res. 2016;148:63\u20139. https:\/\/doi.org\/10.1016\/j.thromres.2016.10.020.","journal-title":"Thromb Res"},{"key":"4576_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.thromres.2021.12.019","volume":"210","author":"F Petrelli","year":"2022","unstructured":"Petrelli F, Cabiddu M, Borgonovo K, Parati MC, Ghilardi M, Perego G, et al. Osimertinib-related venous thromboembolism in non small lung cancer. Thromb Res. 2022;210:63\u20136. https:\/\/doi.org\/10.1016\/j.thromres.2021.12.019.","journal-title":"Thromb Res"},{"issue":"2","key":"4576_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"JC Soria","year":"2018","unstructured":"Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, et al. Osimertinib in Untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med. 2018;378(2):113\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1713137.","journal-title":"N Engl J Med"},{"issue":"7","key":"4576_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1612674","volume":"376","author":"TS Mok","year":"2017","unstructured":"Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, et al. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N Engl J Med. 2017;376(7):629\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1612674.","journal-title":"N Engl J Med"},{"issue":"4","key":"4576_CR8","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1016\/j.cllc.2018.04.004","volume":"19","author":"YL Wu","year":"2018","unstructured":"Wu YL, Herbst RS, Mann H, Rukazenkov Y, Marotti M, Tsuboi M. ADAURA: Phase III, Double-blind, randomized study of osimertinib versus Placebo in EGFR mutation-positive Early-stage NSCLC after complete surgical resection. Clin Lung Cancer. 2018;19(4):e533\u20136. https:\/\/doi.org\/10.1016\/j.cllc.2018.04.004.","journal-title":"Clin Lung Cancer"},{"issue":"21","key":"4576_CR9","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","volume":"389","author":"D Planchard","year":"2023","unstructured":"Planchard D, J\u00e4nne PA, Cheng Y, Yang JC, Yanagitani N, Kim SW, et al. Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC. N Engl J Med. 2023;389(21):1935\u201348. https:\/\/doi.org\/10.1056\/NEJMoa2306434.","journal-title":"N Engl J Med"},{"issue":"7","key":"4576_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2402614","volume":"391","author":"S Lu","year":"2024","unstructured":"Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, et al. Osimertinib after chemoradiotherapy in stage III EGFR-mutated NSCLC. N Engl J Med. 2024;391(7):585\u201397. https:\/\/doi.org\/10.1056\/NEJMoa2402614.","journal-title":"N Engl J Med"},{"issue":"25","key":"4576_CR11","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","volume":"343","author":"HT S\u00f8rensen","year":"2000","unstructured":"S\u00f8rensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846\u201350. https:\/\/doi.org\/10.1056\/NEJM200012213432504.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"4576_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1538-7836.2007.02497.x","volume":"5","author":"HR Buller","year":"2007","unstructured":"Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost. 2007;5(Suppl 1):246\u201354. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02497.x.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"4576_CR13","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20130057","volume":"33","author":"LG Lima","year":"2013","unstructured":"Lima LG, Monteiro RQ. Activation of blood coagulation in cancer: implications for tumour progression. Biosci Rep. 2013;33(5):e00064. https:\/\/doi.org\/10.1042\/BSR20130057.","journal-title":"Biosci Rep"},{"key":"4576_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2020.04.018","volume":"134","author":"F Wolpert","year":"2020","unstructured":"Wolpert F, Berghoff AS, Grossenbacher B, Lareida A, L\u00f6b R, Roth P, et al. Venous thromboembolic events in patients with brain metastases: the PICOS score. Eur J Cancer. 2020;134:75\u201385. https:\/\/doi.org\/10.1016\/j.ejca.2020.04.018.","journal-title":"Eur J Cancer"},{"issue":"16","key":"4576_CR15","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1200\/JCO.22.00255","volume":"41","author":"A Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz A, Ay C, Grilz E, L\u00f3pez S, Font C, Pach\u00f3n V, et al. A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: a development and validation study involving two independent prospective cohorts. J Clin Oncol. 2023;41(16):2911\u201325. https:\/\/doi.org\/10.1200\/JCO.22.00255.","journal-title":"J Clin Oncol"},{"issue":"16","key":"4576_CR16","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1200\/JCO.22.01542","volume":"41","author":"A Li","year":"2023","unstructured":"Li A, La J, May SB, Guffey D, da Costa Jr WL, Amos CI, et al. Derivation and validation of a clinical risk assessment model for cancer-associated thrombosis in two unique us health care systems. J Clin Oncol. 2023;41(16):2926\u201338. https:\/\/doi.org\/10.1200\/JCO.22.01542.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04576-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:36:24Z","timestamp":1790793384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04576-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":16,"alternative-id":["4576"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04576-2","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"31 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conficts of interest related to the development of this research project.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was submitted to the Ethics Committee of each participating center and obtained the corresponding approval prior to its commencement. The processing, communication, and transfer of all personal data complied with the provisions of Organic Law 15\/1999, dated December 13, 1999, regarding the protection of personal data and of Organic Law 3\/2018, dated December 5, 2018, since it came into force.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}